These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4145227)

  • 1. Behavioral differences between acute and chronic schizophrenics: course of psychosis, effects of institutionalization, or sampling biases?
    Strauss ME
    Psychol Bull; 1973 May; 79(5):271-9. PubMed ID: 4145227
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific indications for different classes of phenothiazines.
    Hollister LE; Overall JE; Kimbell I; Pokorny A
    Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
    [No Abstract]   [Full Text] [Related]  

  • 3. A schizophrenic patient who resists phenothiazines.
    Frances A; Carpenter WT
    Hosp Community Psychiatry; 1983 Feb; 34(2):115-6. PubMed ID: 6131029
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of phenothiazine withdrawal on proverb interpretation by chronic schizophrenics.
    Chapman LJ; Cameron R; Cocke JG; Pritchett T
    J Abnorm Psychol; 1975 Feb; 84(1):24-9. PubMed ID: 234133
    [No Abstract]   [Full Text] [Related]  

  • 5. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 6. Concrete operational thinking, diagnosis, and psychopathology in hospitalized schizophrenics.
    Sollod R; Lapidus LB
    J Abnorm Psychol; 1977 Apr; 86(2):199-202. PubMed ID: 858838
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow.
    Hollister LE
    Adv Biochem Psychopharmacol; 1974; 9(0):667-73. PubMed ID: 4151921
    [No Abstract]   [Full Text] [Related]  

  • 8. The relationship of the brief psychiatric rating scale to neuropsychological deficits in phenothiazine-treated schizophrenics.
    Golden CJ; Carpenter B; Wilkening G; Ruedrich S; Chu CC; Graber B
    Psychopharmacol Bull; 1983; 19(3):513-7. PubMed ID: 6138799
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychological medicine. Schizophrenia and related paranoid psychoses.
    Kennedy PF
    Br Med J; 1975 May; 2(5965):257-60. PubMed ID: 236808
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the onset and time course of the effects of neuroleptics.
    Lipper S
    Am J Psychiatry; 1990 Jun; 147(6):814. PubMed ID: 1971498
    [No Abstract]   [Full Text] [Related]  

  • 11. A word association measure of severity of current symptoms in schizophrenia.
    De Wolfe AS
    J Clin Psychol; 1973 Jan; 29(1):11-4. PubMed ID: 4405163
    [No Abstract]   [Full Text] [Related]  

  • 12. Gender differences in cognition in schizophrenia.
    Perlick D; Mattis S; Stastny P; Teresi J
    Schizophr Res; 1992 Oct; 8(1):69-73. PubMed ID: 1358186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia.
    Manschreck TC; Redmond DA; Candela SF; Maher BA
    J Neuropsychiatry Clin Neurosci; 1999; 11(4):481-9. PubMed ID: 10570762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics.
    Spohn HE; Coyne L
    Brain Cogn; 1993 Sep; 23(1):28-39. PubMed ID: 8105820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The catamnesis of schizophrenics in comparison to previous hospital treatment].
    Efimenko VL; Kabanov MM; Gorelik BM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):559-64. PubMed ID: 4267490
    [No Abstract]   [Full Text] [Related]  

  • 16. [Psychopathometric study of the prognostic significance of psychopathologic findings and premorbid personality for discharge of neuroleptic treated patients with schizophrenic psychoses].
    Möller HJ; von Zerssen D
    Nervenarzt; 1985 Sep; 56(9):498-505. PubMed ID: 2867479
    [No Abstract]   [Full Text] [Related]  

  • 17. Auditory signal detection in paranoid and nonparanoid schizophrenics.
    Rappaport M; Hopkins HK; Hall K
    Arch Gen Psychiatry; 1972 Dec; 27(6):747-52. PubMed ID: 4404700
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia.
    Scully PJ; Coakley G; Kinsella A; Waddington JL
    Psychol Med; 1997 Nov; 27(6):1303-10. PubMed ID: 9403902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery from schizophrenic psychosis.
    Szymanski HV; Simon JC; Gutterman N
    Am J Psychiatry; 1983 Mar; 140(3):335-8. PubMed ID: 6131613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
    Mann J; Thomas KM
    Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.